世界における骨移植片/骨代用材の製品パイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Bone Grafts and Substitutes - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Bone Grafts and Substitutes Overview 17
3 Products under Development 18
3.1 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 18
3.2 Bone Grafts and Substitutes – Pipeline Products by Segment 19
3.3 Bone Grafts and Substitutes – Pipeline Products by Territory 20
3.4 Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 21
3.5 Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 22
3.6 Bone Grafts and Substitutes – Ongoing Clinical Trials 23
4 Bone Grafts and Substitutes – Pipeline Products under Development by Companies 24
4.1 Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 24
4.2 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 28
5 Bone Grafts and Substitutes Companies and Product Overview 32
5.1 aap Implantate AG Company Overview 32
5.1.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 32
5.2 Accelerated Orthopedic Technologies, Inc. Company Overview 35
5.2.1 Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Adaptaide Inc. Company Overview 36
5.3.1 Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Adocia Company Overview 37
5.4.1 Adocia Pipeline Products & Ongoing Clinical Trials Overview 37
5.5 Advanced Biologics, LLC Company Overview 41
5.5.1 Advanced Biologics, LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 Agenta Biotechnologies, Inc. Company Overview 42
5.6.1 Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Allergan, Inc. Company Overview 43
5.7.1 Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Alphatec Holdings, Inc. Company Overview 46
5.8.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.9 Amedica Corporation Company Overview 48
5.9.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Anika Therapeutics, Inc. Company Overview 50
5.10.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.11 ApaTech Limited (Inactive) Company Overview 53
5.11.1 ApaTech Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.12 Aperion Biologics Corporation Company Overview 55
5.12.1 Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview 55
5.13 Arthro Kinetics AG Company Overview 62
5.13.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Aursos, Inc Company Overview 63
5.14.1 Aursos, Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Berkeley Advanced Biomaterials, Inc. Company Overview 64
5.15.1 Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Bio2 Technologies, Inc. Company Overview 67
5.16.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 Bioactive Bone Substitutes Ltd. Company Overview 68
5.17.1 Bioactive Bone Substitutes Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 Bioregeneration Technologies, Inc Company Overview 69
5.18.1 Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Bio-Scaffold International Pte Ltd Company Overview 70
5.19.1 Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 BioSET, Inc Company Overview 74
5.20.1 BioSET, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.21 Bioventus LLC Company Overview 81
5.21.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.22 Body Organ Biomedical Corp. Company Overview 83
5.22.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Bone Solutions, Inc. Company Overview 85
5.23.1 Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.24 BoneGrafix, Inc. Company Overview 90
5.24.1 BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.25 BoneSupport AB Company Overview 91
5.25.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 91
5.26 Calcitec, Inc. Company Overview 95
5.26.1 Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.27 Cellright Technologies, LLC Company Overview 96
5.27.1 Cellright Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 96
5.28 CeraPedics, Inc. Company Overview 97
5.28.1 CeraPedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.29 Chinese University of Hong Kong Company Overview 104
5.29.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 104
5.30 Citrics Biomedical, LLC Company Overview 105
5.30.1 Citrics Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
5.31 CollPlant Ltd. Company Overview 106
5.31.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.32 ConMed Corporation Company Overview 108
5.32.1 ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.33 CoreBone Ltd. Company Overview 110
5.33.1 CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 110
5.34 ElutInc Company Overview 111
5.34.1 ElutInc Pipeline Products & Ongoing Clinical Trials Overview 111
5.35 EpiBone Company Overview 112
5.35.1 EpiBone Pipeline Products & Ongoing Clinical Trials Overview 112
5.36 Exactech, Inc. Company Overview 113
5.36.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.37 Graftoss Limited Company Overview 115
5.37.1 Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview 115
5.38 Graftys SAS Company Overview 116
5.38.1 Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview 116
5.39 Inion Oy Company Overview 122
5.39.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Innovia LLC Company Overview 123
5.40.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.41 Innovoss Inc. Company Overview 124
5.41.1 Innovoss Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.42 Integra LifeSciences Holdings Corporation Company Overview 125
5.42.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.43 ISTO Technologies, Inc. Company Overview 127
5.43.1 ISTO Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.44 Jellagen Pty Ltd Company Overview 128
5.44.1 Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 128
5.45 kasios sas Company Overview 129
5.45.1 kasios sas Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Kensey Nash Corporation (Inactive) Company Overview 130
5.46.1 Kensey Nash Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 130
5.47 Kytogenics Pharmaceuticals, Inc. Company Overview 131
5.47.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131
5.48 Lacerta Technologies GmbH Company Overview 132
5.48.1 Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 132
5.49 Mariel Therapeutics, Inc. Company Overview 134
5.49.1 Mariel Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Maxigen Biotech Inc. Company Overview 135
5.50.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Medtronic plc Company Overview 138
5.51.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Meta Biomed Co., Ltd. Company Overview 142
5.52.1 Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 Miromatrix Medical Inc. Company Overview 144
5.53.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.54 N2 Biomedical Company Overview 145
5.54.1 N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 145
5.55 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 146
5.55.1 National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 146
5.56 Noraker Company Overview 147
5.56.1 Noraker Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 NovaBone Products, LLC. Company Overview 149
5.57.1 NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 Nutech Medical, Inc Company Overview 150
5.58.1 Nutech Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 NuVasive, Inc. Company Overview 151
5.59.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.60 Orthogen LLC Company Overview 155
5.60.1 Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.61 OssiFi, Inc. Company Overview 156
5.61.1 OssiFi, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.62 OsteoNovus, LLC Company Overview 157
5.62.1 OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 157
5.63 PolyPid, Ltd. Company Overview 158
5.63.1 PolyPid, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.64 Promimic AB Company Overview 160
5.64.1 Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 160
5.65 ReCaPP Company Overview 161
5.65.1 ReCaPP Pipeline Products & Ongoing Clinical Trials Overview 161
5.66 RepRegen Ltd. (Inactive) Company Overview 162
5.66.1 RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 162
5.67 Revivicor, Inc. Company Overview 164
5.67.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164
5.68 RTI Surgical, Inc. Company Overview 166
5.68.1 RTI Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.69 Sanofi Company Overview 168
5.69.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 168
5.70 SIRAKOSS Limited Company Overview 170
5.70.1 SIRAKOSS Limited Pipeline Products & Ongoing Clinical Trials Overview 170
5.71 Soft Tissue Regeneration, Inc. Company Overview 171
5.71.1 Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.72 Soteira Inc. Company Overview 175
5.72.1 Soteira Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.73 Spineway Company Overview 176
5.73.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 176
5.74 SurgaColl Technologies Ltd Company Overview 178
5.74.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 178
5.75 TBF Genie Tissulaire Company Overview 181
5.75.1 TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview 181
5.76 The Johns Hopkins University Company Overview 183
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.77 Tissue Regeneration Systems, Inc. Company Overview 184
5.77.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.78 Trinity College Dublin Company Overview 185
5.78.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.79 University of California, San Diego Company Overview 186
5.79.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 186
5.80 University of Edinburgh Company Overview 187
5.80.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 187
5.81 University of Memphis Company Overview 189
5.81.1 University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 189
5.82 University of Nottingham’s School Of Pharmacy Company Overview 190
5.82.1 University of Nottingham’s School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview 190
5.83 University of Pecs Company Overview 191
5.83.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 191
5.84 University of South Florida Company Overview 192
5.84.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.85 Wayne State University Company Overview 193
5.85.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 Wound Management Technologies, Inc. Company Overview 194
5.86.1 Wound Management Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 Wright Medical Group, Inc. Company Overview 196
5.87.1 Wright Medical Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 X-spine Systems, Inc. Company Overview 203
5.88.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.89 Xtant Medical Holdings, Inc. Company Overview 204
5.89.1 Xtant Medical Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
6 Bone Grafts and Substitutes- Recent Developments 207
7 Appendix 267
7.1 Methodology 267
7.2 About GlobalData 269
7.3 Contact Us 270
7.4 Disclaimer 270


【レポート販売概要】

■ タイトル:世界における骨移植片/骨代用材の製品パイプライン動向2015
■ 英文:Bone Grafts and Substitutes - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0079EPD
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。